-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Filip - @tokenized_cro
community/marketing @dhealth_network, ghostwriter, smtimes writer @ medium.com/ @filip.milner, 📩 for inquiries
Dubosky - @duboskyMusica
Cantautor de La @MaximaBandera y @PanamaMusic • @DuboskyFC
Sponsored by SpokeoPaid Service
Filip N Dubovsky
F*****@gmail.com — (240) 715-****
***** West Ave, Apt 1511, Miami Beach, FL
View full reportSponsored by SpokeoPaid Service
Filip Dubovsky
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Filip Dubovsky - @martiniquealexander
Make your gift more impressed 😎😍🎄
45 followers
filipdubovsky - @filipdubovsky1
62 followers
filipdubovsky08 - @rannytv0
FOLOW AND SUBSRIBE TO MY CHANEL!! 🔥🔥!!
48 followers
Filip Dubovsky
Sabin Vaccine Institute
Stacie Lambert
Gilead Sciences
Roderick Tang
Meissa Vaccines
Education: University of Colorado, ...
Filip Dubovsky
-
Indian Springs School (1979 - 1983)
Helena, AL
Filip Dubovsky
Sponsored by PeopleLookerPaid Service
Search for Filip Dubovsky's city and state history
Search address historyCampaign contribution records
Filip Dubovsky
Scientist at Medimmune
OBAMA FOR AMERICA (2012)
OBAMA VICTORY FUND 2012 (2012)
PRIORITIES USA ACTION (2012)
DNC SERVICES CORPORATION/DEMOCRATIC NATIONAL COMMITTEE (2008)
Filip Dubovsky
DNC SERVICES CORPORATION/DEMOCRATIC NATIONAL COMMITTEE (2004)
Websites owned by Filip Dubovsky
easyreklama.sk
Registered on January 11, 2019
Novavax’s R&D head, integral to Covid vaccine work, to retire
The Business Journals - Wed, 29 May 2024
Whatever happened to the Novavax Covid vaccine?
BBC - Sat, 16 Apr 2022
Novavax XBB.1.5 COVID-19 Vaccine Adds Value
Vax-Before-Travel - Tue, 12 Sep 2023
Novavax says vaccine targeting Covid and flu shows promising results in early data
CNBC - Wed, 20 Apr 2022
New COVID-19 vaccine expected by end of September
WPTV - Wed, 09 Aug 2023
Preparing for fall and winter: Importance of COVID-19 vaccination during the flu season [PODCAST]
KevinMD.com - Tue, 15 Nov 2022
Novavax Appoints Denny Kim SVP
citybiz - Mon, 04 Oct 2021
Up and down the ladder: The latest comings and goings
statnews.com - Fri, 13 Nov 2020
From AstraZeneca to Novavax: Serum Institute wins FDA nod to supply new COVID shot to US from India
Fierce Pharma - Fri, 15 Jul 2022
Filip Dubovsky - @filipdubovsky
383 photos - 1 follower
Filip Dubovsky - @fdubovsky
3 followers
Filip Dubovský - @objednavkyeasy
0 followers
Filip Dubovský - @fdubovsk
0 followers
Filip Dubovský - @filipdubovsk
1 follower
Filip Dubovský - @filipdubovsky
0 followers
Filip Dubovsky - Chief Medical Officer @ Novavax
www.crunchbase.com
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - December 2022 Production
US Government, obtained by KEI
2022
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - November 2023 Production
US Government, obtained by KEI
2023
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - October 2023 Production
US Government, obtained by KEI
2023
Defender Robert F Kennedy Jr.
John Burns UMOJA Research
2021
Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children.
Lievens, Marc,Aponte, John J,Williamson, John,Mmbando, Bruno,Mohamed, Ali,Bejon, Philip,Leach, Amanda
2011
DTIC ADA513498: Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Defense Technical Information Center
2009
They Knew The Jab Was Dangerous
@superzar_pro
2025
Commencement 1991-2000
Johns Hopkins University
1991
C19 Threads Dec2023-Feb2024 116pg Ralph Baric
Destiny Rezendes
2024
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - February 2024 Production
US Government, obtained by KEI
2024
Hartford Courant -- June 8, 2022
Hartford Courant
2022
Shelby County Reporter May - June 1983
Ralph and Marcia Sears
1983
Filip Dubovsky - Sabin Vaccine Institute
Filip Dubovsky is a pediatric infectious disease specialist and public health physician with extensive experience in developing vaccines and treatments for ...
Dr. Filip Dubovsky, MD - Pediatric Infectious Disease - Doximity
Dr. Filip Dubovsky, MD is a pediatric infectious disease specialist in Gaithersburg, Maryland. He is currently licensed to practice medicine in Maryland, ...
Filip Dubovsky, Novavax Inc: Profile and Biography - Bloomberg
Filip Dubovsky is Former President:Research & Development at Novavax Inc. See Filip Dubovsky's compensation, career history, education, & memberships.
Dr. Filip Dubovsky, MD - Infectious Diseases Pediatrician in ...
Dr. Filip Dubovsky, MD is an infectious diseases pediatrician in Gaithersburg, MD and has over 30 years of experience in the medical field.
Filip Dubovsky - Semantic Scholar
Semantic Scholar profile for Filip Dubovsky, with 2 highly influential citations and 1 scientific research papers.
Filip Dubovsky | Novavax | 7 Publications | 607 Citations | Related ...
Filip Dubovsky is an academic researcher from Novavax. The author has contributed to research in topics: Reactogenicity & Placebo.
Novavax outgoing R&D head Filip Dubovsky reflects on 4 years ...
Dr. Filip Dubovsky was the first person to see the clinical results from Novavax's initial Covid-19 vaccine study in 2020.
People - Sabin Vaccine Institute
Filip Dubovsky. Trustee. Headshot of Amy Finan in front of a window. Amy Finan. Chief Executive Officer. Elizabeth Fox. Trustee. Axel Hoos.
Novavax Announces Additions to Executive Leadership
Filip Dubovsky, MD, MPH, FAAP, has been appointed Senior Vice President and Chief Medical Officer, where he will oversee Novavax' medical and clinical affairs.
Filip Dubovsky Net Worth (2026) - GuruFocus
Filip Dubovsky is the President, R&D of Novavax Inc and owns about 66,613 shares of Novavax Inc (NVAX) stock worth over $654,140. Details can be seen in Filip ...
Filip Dubovsky: Positions, Relations and Network
Presently, Filip Dubovsky holds the position of Chief Medical Officer & Executive Vice President at Novavax, Inc. He is also on the board of Albert B. Sabin ...
Filip Dubovsky | MedImmune/AstraZeneca, USA
Filip Dubovsky is a Vice President in Clinical Biologics and the Therapeutic Area Head for Infectious Disease and Vaccines at MedImmune/AstraZeneca. He has a BA ...
Filip Dubovsky's research works | University of Maryland, Baltimore ...
Filip Dubovsky's 3 research works with 391 citations, including: Heterogeneous Virulence of Enteroaggregative Escherichia coli Strains Isolated from ...
Progress towards the development of malaria vaccines - PubMed
Authors. Elissa Malkin , Filip Dubovsky, Melinda Moree. Affiliation. 1 PATH Malaria Vaccine Initiative, 7500 Old Georgetown Road, Bethesda, MD 20814, USA ...
Dr Filip Dubovsky - News, Articles etc. - European Pharmaceutical ...
News stories and articles referencing Dr Filip Dubovsky on European Pharmaceutical Review.
Data in Support of Novavax XBB.1.5 Vaccine - CDC Stacks
Data in Support of Novavax XBB.1.5 Vaccine Dr. Filip Dubovsky, President, Research & Development September 12, 2023 1. More Information
[PDF] Vaccines and Related Biological Products Advisory Committee ...
Filip Dubovsky, MD, MPH, FAAP. Executive Vice President & Chief Medical Officer, Novavax, Inc. Immunogenicity and Efficacy. Raburn Mallory, MD.
Dr. Filip Dubovsky | Gaithersburg, MD | Public Health & General ...
Dr. Filip Dubovsky, is a specialist in public health & general preventive medicine who treats patients in Gaithersburg, MD. This provider has 35 years of ...
A Passive Vaccine Approach to Respiratory Syncytial Virus ...
Filip Dubovsky ,. Filip Dubovsky. Search for other works by this author on: Oxford Academic · Google Scholar. Gabriel J. Robbie. Gabriel J. Robbie. Search for ...
Experiences of Filip Dubovsky: Current and past positions ...
Filip Dubovsky. Director/Board Member at. Albert B. Sabin Vaccine Institute, Inc. Net worth: 469 622 $ as of 2025-11-29. 61 year. 14 connections.
Filip Dubovsky - Medtech Alert
Filip Dubovsky. About Filip Dubovsky. Related Story. COVID-19. Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed ...
Novavax's R&D head, integral to Covid vaccine work, to retire
Dr. Filip Dubovsky, the Gaithersburg biotech's president of R&D, plans to retire June 30, the company reported Thursday to the Securities and ...